Cargando…
Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
Previous studies have found that tumor-associated macrophages (TAMs) promote cancer progression. We previously reported that TAMs promote prostate cancer metastasis via activation of the CCL2–CCR2 axis. The CCR4 (receptor of CCL17 and CCL22) expression level in breast cancer was reported to be assoc...
Autores principales: | Maolake, Aerken, Izumi, Kouji, Shigehara, Kazuyoshi, Natsagdorj, Ariunbold, Iwamoto, Hiroaki, Kadomoto, Suguru, Takezawa, Yuta, Machioka, Kazuaki, Narimoto, Kazutaka, Namiki, Mikio, Lin, Wen-Jye, Wufuer, Guzailinuer, Mizokami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354767/ https://www.ncbi.nlm.nih.gov/pubmed/28039457 http://dx.doi.org/10.18632/oncotarget.14185 |
Ejemplares similares
-
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells
por: Natsagdorj, Ariunbold, et al.
Publicado: (2018) -
C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
por: Urata, Satoko, et al.
Publicado: (2018) -
Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
por: Maolake, Aerken, et al.
Publicado: (2018) -
Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
por: Machioka, Kazuaki, et al.
Publicado: (2018) -
Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2015)